KS

KMC Speciality Hospitals (India) Ltd

Q1 FY27Healthcare Services

KMC Speciality Hospitals (India) Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.

Based on KMC Speciality Hospitals (India) Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹156
Market cap₹2.5K Cr
P/E43.9

The short version

Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. EBITDA for Q1 FY'27 is INR 30.3 Cr, up 76% from INR 17.3 Cr in Q1 FY'26.

From KMC Speciality Hospitals (India) Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26.
  • Q1 FY'27 Total Income: INR 93.6 Cr, up 39% YoY from INR 67.4 Cr in Q1 FY'26.
  • Q1 FY'27 EBITDA: INR 30.3 Cr, up 76% YoY from INR 17.3 Cr in Q1 FY'26.
  • Q1 FY'27 PAT: INR 16.6 Cr, up 120% YoY from INR 7.5 Cr in Q1 FY'26.
  • Occupied Bed Days: 25,732 in Q1 FY'27, 25% increase YoY from 20,642 in Q1 FY'26.

2 more points from KMC Speciality Hospitals (India) Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what KMC Speciality Hospitals (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • New facility "Maa Kauvery" commenced operations from January 2024 (Page 29).
  • Loan availed specifically for "Maa Kauvery" facility; total borrowings for this new facility were INR 68.3 Cr as of 30th June 2026 (Page 21).
  • Capital Work In Progress (CWIP) reported as INR 1.57 Cr as of June 2026, compared to nil in FY’26 (Page 21).

2 more points from KMC Speciality Hospitals (India) Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what KMC Speciality Hospitals (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what KMC Speciality Hospitals (India) Ltd said on order book & pipeline — free account, 30 seconds.

KMC Speciality Hospitals (India) Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024Q2 FY25
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹82 Cr, net profit ₹14 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What KMC Speciality's management said in earlier quarters

Others in Healthcare Services this season

  • Aatmaj Health (Q1 FY27)

    Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again

  • Asarfi Hospital (Q1 FY27)

    Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q

  • 3B Blackbio (Q1 FY27)

    Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…

  • Thyrocare Technologies (Q1 FY27)

    Pathology business grew ~27%; franchisee business grew ~23-27% YoY, reflecting strong volume growth. Key concall takeaways from Thyrocare Technologies Ltd's Q1…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

KMC Speciality Hospitals (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were KMC Speciality Hospitals (India) Ltd Q1 FY27 results?

Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. EBITDA for Q1 FY'27 is INR 30.3 Cr, up 76% from INR 17.3 Cr in Q1 FY'26.

What is KMC Speciality Hospitals (India) Ltd share price analysis?

KMC Speciality Hospitals (India) Ltd currently shows a neutral. The stock trades at a P/E of 43.9 with a market cap of ₹2,451 Cr. Investors should review the full earnings analysis for detailed insights.

Is KMC Speciality Hospitals (India) Ltd planning capital expenditure?

New facility "Maa Kauvery" commenced operations from January 2024 (Page 29).

Keep KMC Speciality Hospitals (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.